Long-term high dose factor VIII treatment of 3 haemophiliacs with factor VIII inhibitor.

3 patients with haemophilia A and inhibitor against Factor VIII were developing progressive haemophiliac arthropathy due to the non-feasibility of prophylactic treatment. In order to suppress inhibitor formation, long-term treatment with high-dose Factor VIII (100 units per kg body weight twice daily) was initiated. Prothrombin complex concentrate was given only for bleeding episodes. Though all 3 patients were high responders, they presented different treatment courses. 2 became low responders after 4 and 11 months' treatment, respectively. 1 patient had no demonstrable inhibitor after start of treatment. In all 3 patients, prophylactic treatment was established, in 1 case still with increased doses compared to non-inhibitor patients. The high-dose Factor VIII treatment makes in possible to provide prophylactic treatment for the high-responder inhibitor patients. However, the extremely high costs represent a serious obstacle to this treatment.

[1]  E. Scheibel,et al.  Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment. , 2009, Scandinavian journal of haematology.

[2]  J. Ingerslev,et al.  Factor VIII inhibitor treatment with high doses of F VIII. , 1984, Thrombosis research.

[3]  J. Curran.  AIDS - two years later. , 1983, Rhode Island dental journal.

[4]  E. Tuddenham,et al.  Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII. , 1984, Blood.

[5]  H. Bliddal,et al.  Circulating Immune Complexes in Hashimoto's Thyroiditis , 1983, Allergy.

[6]  G. White,et al.  Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a case. , 1983, Blood.

[7]  M. Lederman,et al.  Impaired cell-mediated immunity in patients with classic hemophilia. , 1983, The New England journal of medicine.

[8]  R. Aster,et al.  T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. , 1983, The New England journal of medicine.

[9]  C. Rizza,et al.  Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs , 1982, British journal of haematology.

[10]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[11]  H. V. van Houwelingen,et al.  The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial. , 1981, The New England journal of medicine.

[12]  Å. Ahlberg,et al.  A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies , 1981 .

[13]  I. Nilsson,et al.  Factor VIII:C and VIII:CAg Response in Patients with Haemophilia A and von Willebrand's Disease after Administration of Different Factor VIII Concentrates or Plasma , 1981, British journal of haematology.

[14]  C. Abildgaard,et al.  Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia , 1980 .

[15]  M. Blombäck,et al.  ARTHROPATHY IN CHILDREN WITH SEVERE HEMOPHILIA A , 1980, Acta paediatrica Scandinavica.

[16]  S. Shapiro,et al.  Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. , 1980, The New England journal of medicine.

[17]  H. Brackmann,et al.  MASSIVE FACTOR-VIII INFUSION IN HÆMOPHILIAC WITH FACTOR-VIII INHIBITOR, HIGH RESPONDER , 1977, The Lancet.

[18]  N. Morling,et al.  Immunological in vitro parameters in patients with multiple sclerosis and in normal individuals. , 2009, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.

[19]  I. Nilsson,et al.  Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. , 2009, Scandinavian journal of haematology.

[20]  S. Shapiro,et al.  Immunosuppressive therapy of Factor VIII inhibitors , 1976 .

[21]  D. Frommel,et al.  Antibodies to factor VIII. V. Patterns of immune response to factor VIII in hemophilia A. , 1976, Blood.

[22]  Å. Ahlberg,et al.  HAEMOPHILIA PROPHYLAXIS IN SWEDEN , 1976, Acta paediatrica Scandinavica.

[23]  E. Bowie,et al.  Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor. , 1975, Blood.

[24]  D. Green,et al.  A More Uniform Measurement of Factor VIII Inhibitors , 1975, Thrombosis and Haemostasis.

[25]  C. Kasper,et al.  Measurement of Mild Factor VIII Inhibitors in Bethesda Units , 1975, Thrombosis and Haemostasis.

[26]  Feinstein Di,et al.  Acquired inhibitors of blood coagulation. , 1972 .

[27]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[28]  S. D. Mohamed,et al.  Abnormal histidine metabolism in thyrotoxicosis in man. A possible index of impaired folate function. , 1965, Lancet.

[29]  K. Brinkhous,et al.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. , 1953, The Journal of laboratory and clinical medicine.